A study has shown that CRISPR can be used as a regenerative technique to treat Duchenne muscular dystrophy, which could be developed as a therapeutic option for humans.
List view / Grid view
Filter the results
A team has used a lentiviral capsid-based bionanoparticle system to deliver CRISPR-Cas9 gene editing therapies, reducing undesired effects.
Researchers have developed a new treatment method which turned glial cells into functioning neurons in mice after stroke.
A clinical study comparing liquid and tissue biopsies finds multiple resistance mechanisms in individual patients.
A research team have found a signalling pathway which plays a critical role in the maturation of periodontal ligament, providing information for the development of dental treatments.
The gut microbiota has been linked to organ damage in patients with sepsis suggesting targeting intestinal microbiota may help patients' recovery.
A new study has shown that mutations in mitochondrial DNA induced by cell reprogramming may trigger an immune response.
A team has developed a technique for identifying pluripotent stem cells that could help research on transplantation medicine.
A research team has developed a method for regenerating old brain stem cells from rat models, which could be used to treat age-related brain diseases.
The ISCT is objecting linking the benefits of cellular immunotherapy with third party offerings of T-cell banking for future therapeutics.
A new 'optochemogenetics' research approach from scientists at the Emory University School of Medicine could aid in helping stroke victims.
A new study shows promise for future neural stem cell therapies in replacing cells lost through disease or injury.
A novel way to create Expanded Potential Stem Cells has generated opportunities to research regenerative medicine.
New findings could be translated into the development of novel treatments for patients with optic neuropathies.
Sartorius Stedim Biotech introduces BIOSTAT® RM TX with Flexsafe® RM TX for producing consistent quality cellular products
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry announced the launch of the BIOSTAT® RM TX single-use bioreactor, a new wave mixed system developed specifically for closed, automated expansion of consistent quality cell products such as ex vivo cellular immunotherapies...